Cardiovascular disease: identifying and supporting people most at risk of dying early

necessarily located in areas defined as disadvantaged. The guidance, therefore, is applicable to these people – regardless of where they live. • PHIAC is mindful that a lack of resources (within the NHS and other sectors) has sometimes confounded attempts to address health inequalities. Adequate resources (financial, time, equipment and people) need to be deployed effectively to meet the needs of people who are disadvantaged. • People who are disadvantaged face social and economic issues that may adversely affect their ability to respond to the treatments or advice on offer. • Few, if any, studies in the effectiveness reviews focused primarily on reducing health inequalities. Studies that did include relevant variables were not usually large enough to analyse outcomes in relation to different subgroups. As a result, it's unclear from these studies which methods are most effective at reaching people or groups that are disadvantaged. Smoking cessation and the provision of statins (both generally agreed to be effective interventions) provide clear pointers on how to meet the needs of people who are disadvantaged. They also form a key part of the government's approach to tackling health inequalities. • PHIAC would like to encourage research trials that are large enough to
